Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 1 OF 11 | DISPLAYING 1 - 15 OF 152 RESULTS

    Mukhopadhyay A. et. al., Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy, https://doi.org/10.1038/s41434-018-0044-5, Gene Therapy, Oct 15, 2018

    Cristescu R. et. al., Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy, 10.1126/science.aar3593 , Science, Oct 12, 2018

    Angelova M. et. al., Evolution of Metastases in Space and Time under Immune Selection, https://doi.org/10.1016/j.cell.2018.09.018, Cell, Oct 11, 2018

    Medler T.R. et. al., Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy, https://doi.org/10.1016/j.ccell.2018.09.003, Cancer Cell, Oct 08, 2018

    Amaria R.N. et. al., Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma, https://doi.org/10.1038/s41591-018-0197-1, Nature Med., Oct 08, 2018

    Blabk C.U. et. al., Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma, https://doi.org/10.1038/s41591-018-0198-0, Nature Med., Oct 08, 2018

    Chang Y.H. et. al., Computational measurement of tumor immune microenvironment in gastric adenocarcinomas, https://doi.org/10.1038/s41598-018-32299-0, Sci. Reports, Sep 17, 2018

    Foulds G.A. et. al., Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer, 10.3389/fimmu.2018.02028, Front Immunol., Sep 11, 2018

    Su B. et. al., hsa-miR-24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c-Myc/epithelial-mesenchymal transition axis, 10.3892/or.2018.6690, Oncol Rep., Sep 07, 2018

    Sugio T. et. al., Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS, 10.1182/bloodadvances.2018018754, Blood Adv., Sep 07, 2018

    Jiang P. et. al., Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response, https://doi.org/10.1038/s41591-018-0136-1, Nature Med., Aug 20, 2018

    Chakravarthy A. et. al., Pan-cancer deconvolution of tumour composition using DNA methylation, https://doi.org/10.1038/s41467-018-05570-1, Nature Commun., Aug 13, 2018

    Kim S-S. et. al., Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor, 10.1080/2162402X.2018.1484982, Oncoimmunology, Aug 01, 2018

    Polumuri S.K. et. al., Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities, https://doi.org/10.1038/s41598-018-29850-4, Sci. Reports, Jul 31, 2018

    Owens G.L. et. al., Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells, 10.1007/s00262-018-2211-3, Cancer Immunol. Immunother., Jul 23, 2018